Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL639857 | 0.71 | CYP2A6 (0.38) | GPR3CYP1A2CYP2A6ALDH1A1HPGD | |
| SCHEMBL2336588 | 0.70 | CYP1A2 (0.41) | GPR3CYP1A2CYP2A6ALDH1A1HPGD | |
| SCHEMBL24030 | 0.70 | GPR3 (0.46) | GPR3CYP1A2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL2514483 | 0.68 | LMNA (0.37) | CYP1A2ALDH1A1HPGDHSD17B10NPC1 | |
| SCHEMBL27656095 | 0.68 | GPR3 (0.44) | GPR3CYP1A2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL558999 | 0.67 | MAOA (0.37) | CYP1A2CYP2A6 | |
| SCHEMBL857662 | 0.67 | LMNA (0.39) | GPR3CYP1A2ALDH1A1HPGDNUDT1 | |
| SCHEMBL1070656 | 0.67 | IDO1 (0.33) | ALDH1A1 | |
| SCHEMBL2358500 | 0.67 | CYP1A2 (0.39) | GPR3CYP1A2CYP2A6ALDH1A1TSHR | |
| SCHEMBL9218409 | 0.66 | ALDH1A1 (0.45) | CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108997438-B | Red phosphorescent compound and organic light emitting diode device using the same | 浙江华显光电科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-108997437-B | Red phosphorescent compound and organic light emitting diode device using the same | 浙江华显光电科技有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-109988193-B | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-109810146-B | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-111116673-A | Red phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-110981913-A | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-110964063-A | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110938097-A | Green phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-03-31 | — | — | CN | claimed |
| CN-110922430-A | Green phosphorescent compound and organic electroluminescent device using same | 宇瑞(上海)化学有限公司 | 2020-03-27 | — | — | CN | claimed |
| CN-110872328-A | Red phosphorescent compound and organic electroluminescent device using the same | 浙江华显光电科技有限公司 | 2020-03-10 | — | — | CN | claimed |
| US-20060204785-A1 | Dopant iridium complexes of 2-alkylphenylquinolines and an alkanedione; dopant of the light emitting layer; host compounds are aluminum or zinc complexes; high color purity, high brightness, and long durability; flat panel displays | LG ELECTRONICS INC. (KR) | 2006-09-14 | — | — | US | claimed |
| WO-2006095943-A1 | RED PHOSPHORESCENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME | LG ELECTRONICS INC. (KR) | 2006-09-14 | — | — | WO | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| JP-2006503013-A | — | — | 2006-01-26 | — | — | JP | claimed |
| EP-1532149-A2 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-05-25 | — | — | EP | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040097510-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-05-20 | — | — | US | claimed |
| WO-2004018468-A2 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-03-04 | — | — | WO | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | GPR3 1918/4885CYP1A2 2390/4885CYP2A6 2765/4885 |
| US-20060204785-A1 | Dopant iridium complexes of 2-alkylphenylquinolines and an alkanedione; dopant of the light emitting layer; host compounds are aluminum or zinc complexes; high color purity, high brightness, and long durability; flat panel displays | KCNQ5, KCNN1, SLC7A5 | GPR3 3870/4885CYP1A2 952/4885CYP2A6 3700/4885 |
| US-20040097510-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | DPP8, DPP4, DPP3 | GPR3 752/4885CYP1A2 313/4885CYP2A6 702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.